Previous studies have demonstrated that TGFα is a more potent agonist for EGFR than EGF in various biological systems23,24, highlighting the significance of CAF-derived TGFα in regulating EGFR-mediated cancer cell chemoresistance. The gene discussed is EGFR; the disease is cancer.